ロード中...
Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
Assessment of minimal residual disease has emerged as a powerful prognostic factor in acute myeloid leukemia. In this study, we investigated the potential of IDH1/2 mutations as targets for minimal residual disease assessment in acute myeloid leukemia, since these mutations collectively occur in 15–...
保存先:
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ferrata Storti Foundation
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5927984/ https://ncbi.nlm.nih.gov/pubmed/29472349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.183525 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|